Public Health News
-
The U.S. Nuclear Regulatory Commission moved closer to imposing tougher safeguards at the nation’s reactors, a year after a disaster in Japan that triggered radiation leaks from a crippled power plant.
-
Updated 1 hour, 5 minutes ago
U.S. regulation of interstate air pollution will have “dramatic” health benefits for 240 million people and should be implemented, the Environmental Protection Agency told a federal appeals court.
-
A majority of the five-member U.S. Nuclear Regulatory Commission voted to issue rules on reactor safety, moving the agency a step closer to enhancing safeguards in response to Japan’s 2011 disaster.
-
Guatemalan President Otto Perez Molina is sparking a bond rally by pledging to tame drug violence that has pushed the murder rate up 60 percent in the past decade and cut into economic growth.
-
The U.S. Food and Drug Administration was blocked by a federal judge from requiring tobacco companies to put graphic health warnings on cigarette packaging.
-
Our family has feasted on two Gambaru Pakku (“Hang in there!” packs) -- boxes of fruit, vegetables and miso from Fukushima Prefecture -- and my wife has just ordered a third. We have bought several cartons of crisp Fukushima apples, too, and almost all of the rice we have consumed since the earthquake last March has also come from the part of Japan known worldwide for its crippled nuclear reactors.
-
The U.S. Environmental Protection Agency’s limits on vehicle and industrial emissions of greenhouse gases including carbon dioxide are being scrutinized by U.S. judges as a two-day court hearing began in Washington.
-
Among all the trials and tribulations that define Greece these days, one that has received relatively little attention is its sky-high smoking rate. Greece’s is the highest in the Organization for Economic Cooperation and Development. Greece is an outlier also in that its smoking rate has risen significantly over the past decade.
-
Tenet Healthcare Corp., the third- largest U.S. hospital operator, reported fourth-quarter earnings that missed analyst estimates after expected reimbursement settlements weren’t received.
-
Merck & Co. may face fines after being almost a year late with a post-market study of its diabetes drugs Januvia and Janumet to determine if the pills inflame the pancreas, U.S. regulators said.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page